InvestorsHub Logo

jakedogman1

09/12/06 7:50 PM

#8632 RE: volgoat #8630

Speculation on my part and relative to my estimate that FDA would require much more given three types of cancers with three different chemo treatments. Do the math on how may samples for each type.

EZLibra

09/12/06 8:11 PM

#8634 RE: volgoat #8630

Tustin would not do India if the results...

...would not translate to stateside trials. And India would not allow trials unless safety had been well established.

SK said one of three sites was ready to roll, and that twelve patients for more than three indications would be recruited. I am hoping that three sites will mean 36 patients. I realize that should not be needed for proof of principle, I'm just looking at a future block in the road. BP deal a la India/whatever should take care of all the 'details'.

Tustin communication had been dismal this summer. "...first, kill all the lawyers"